Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model

Protein Expression and Purification

Volumn 59, Issue 2, 2008, Pages 189-196

  Bai, Yinlan ^a   Xue, Ying ^a   Gao, Hui ^a   Wang, Limei ^a   Ding, Tianbing ^a   Bai, Wentao ^a   Fan, Ailin ^b   Zhang, Jianfang ^b   An, Qunxing ^b   Xu, Zhikai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ESAT 6; Expression; MPT64; Mycobacterium tuberculosis; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GAMMA INTERFERON; INTERLEUKIN 12; MPB64 PROTEIN, MYCOBACTERIUM; NITRILOTRIACETIC ACID; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; ESCHERICHIA COLI; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR CLONING; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN FOLDING; TUBERCULOSIS; WESTERN BLOTTING;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NITRILOTRIACETIC ACID; PROTEIN FOLDING; RECOMBINANT PROTEINS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 42749092014     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.11.016     Document Type: Article

References (28)

1. World Health Organization. Global Tuberculosis Control-Surveillance, Planning, Financing, WHO Report, Geneva, Switzerland, 2006.
2. Fine P.E. Variation in protection by BCG: implication of and for heterologous immunity. Lancet 346 (1995) 1339-1345
3. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Genties S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
4. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. Bacteriology 178 (1996) 1274-1282
5. Gordon S.V., Brosch R., Billault A., Garnier T., Eiglmeier K., and Cole S.T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32 (1999) 643-655
6. Haga S., Yamaguchi R., Nagai S., Matsuo K., Yamazaki A., and Nakamura R.M. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. Leukoc. Biol. 57 (1995) 221-225
7. Collins D.M., and De Lisle G.W. BCG identification by DNA restriction fragment patterns. Gen. Microbiol. 133 (1987) 1431-1435
8. Kamath A.T., Feng C.G., Macdonald M., Briscoe H., and Britton W.J. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67 (1999) 1702-1707
9. Rook G.A.W., Seah G., and Ustianowski A.M. Tuberculosis: immunology and vaccination. Eur. Respir. J. 17 (2001) 537-557
10. Behr M.A., and Small P.M. Has BCG attenuated to impotence?. Nature 389 (1997) 133-134
11. Brandt L., Cunha J.F., Olsen A.W., Elhay M., and Rosenkrands I. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70 (2002) 672-678
12. Skjot R.L., Oettinger T., Rosenkrands I., Ravn P., Brock I., Jacobsen S., and Andersen P. Comparative evaluation of Low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T cell antigens. Infect Immun. 68 (2000) 214-220
13. Elhay M.J., Oettinger T., and Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun. 66 (1998) 3454-3456
14. Brusasca P.N., Peters R.L., Motzel S.L., Klein H.J., Gennaro M.L., Brusasca P.N., Peters R.L., Motzel S.L., Klein H.J., and Gennaro M.L. Antigen recognition by serum antibodies in non-human primates experimentally infected with Mycobacterium tuberculosis. Comp. Med. 53 (2003) 165-172
15. Demissie A., Ravn P., Olobo J., Doherty T.M., Eguale T., Geletu M., Hailu W., Andersen P., and Britton S. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect. Immun. 67 (1999) 5967-5971
16. Skeiky Y.A., Lodes M.J., Guderian J.A., Mohamath R., Bement T., Alderson M.R., and Reed S.G. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect. Immun. 67 (1999) 3998-4007
17. Bai Y.L., LI Y., LI B.H., XUE Y., and FAN X.L. Cloning and expression of secreted protein MPT64 of Mycobacterium tuberculosis. J. Fourth Mil. Med. Univ. 24 (2003) 43-45
18. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, New York pp. 880-897
19. Roche P.W., Winter N., Triccas J.A., Feng C.G., and Britton W.J. Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycobacterium smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin. Exp. Immunol. 103 (1996) 226-232
20. Coler R.N., Skeiky Y.A., Ovendale P.J., Vedvick T.S., Gervassi L., Guderian J., Jen S., Reed S.G., and Campos-Neto A. Cloning of a Mycobacterium tuberculosis gene encoding a purified protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J. Infect. Dis. 182 (2000) 224-233
21. Wang A., Clapper J., Guderian J.A., Foy T.M., Fanger G.R., Retter M.W., and Skeiky Y.A.W. A novel method for increasing the expression level of recombinant proteins. Protein Expr. Purif. 30 (2003) 124-130
22. Orme I., Miller E., and Roberts A. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Immunol. 2001 148 (2001) 189-196
23. Bao L., Chen W., Zhang H., and Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis Bacillus Calmette-Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect. Immun. 71 (2003) 1656-1666
24. Anderson P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62 (1994) 2536-2544
25. Orme I.M. Current progress in tuberculosis vaccine development. Vaccine 23 (2005) 2105-2108
26. Olsen A.W., Williams A., Okkels L.M., Hatch G., and Andersen P. Protection of Mice with a Tuberculosis subunit vaccine based on a fusion protein of Antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect. Immun. 72 (2004) 6148-6150
27. Martin J.E., Thomas O., and Peter A. Delayed -type hypersensitivity response to ESAT-6 and MPT64 from M. tuberculosis in the guinea pig. Infect. Immun. 66 (1998) 3454-3456
28. Arend S.M., Andersen P., van Meijgaarden K.E., Skjot R.L., Subronto Y.W., van Dissel J.T., and Ottenhoff T.H. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181 (2000) 1850-1854